A live biotherapeutic product for adult allogeneic hematopoietic cell transplantation recipients: a partially randomized, placebo-controlled phase 1b trial
EthicsStudy SER-155-001 was a two-part first-in-human phase 1b clinical study performed in accordance with Good Clinical Practice Gui...
